Pilot and Feasibility Program Awardees
2024 Pilot & Feasibility Grant Awardees
Assistant Professor
Renewal
The Role of Fic-mediated AMPylation in Metabolic Disease
Dr. Casey will study the role of cell stress pathways in cells that regulate metabolism during the course of diet-induced obesity. She will use a novel genetically modified mouse model to investigate the role of cell stress in several key tissues regulating blood glucose levels and whole-body metabolism.
Assistant Instructor
Mechanisms for adiposity link to HFpEF in human subjects
Kelseanna Hollis-Hansen, Ph.D.
Assistant Professor
Identifying strategies to curtail weight regain after GLP-1 receptor agonist treatment cessation
Assistant Professor
Impact of vitamin C on genome methylation in developing CNS
2023 Pilot & Feasibility Grant Awardees
Assistant Professor
The Role of Fic-mediated AMPylation in Metabolic Disease
Dr. Casey will study the role of cell stress pathways in cells that regulate metabolism during the course of diet-induced obesity. She will use a novel genetically modified mouse model to investigate the role of cell stress in several key tissues regulating blood glucose levels and whole-body metabolism.
Assistant Instructor
Etv5 and the Regulation of Body Weight Homeostasis
Dr. Gahlot will investigate the role of a recently identified regulator of the expression of the neuropeptide proopiomelanocortin in neurons of the hypothalamus. She will investigate the effects of deleting this gene in the context of diet-induced obesity and diabetes in a mouse model.
Assistant Professor
Regulation of Obesity and Metabolism by Hepatic ISGylation
Dr. Patel will follow up on his previous studies which identified a novel modification of proteins. Dr. Patel will now investigate the mechanisms and significance of this novel modification for key proteins in the liver to impact obesity and insulin resistance.
Assistant Professor
Tirzepatide-induced Weight Loss on Cognitive and Brain Function in Older Adults with Obesity
Dr. Thomas will use functional brain imaging techniques to assess the effects of a novel diabetes drug on brain function. These studies will be performed in subjects with obesity before and after treatment with this anti-diabetic drug and will assess cognitive function during the course of the study.